It is well known that radiation damage of the pharyngeal constrictor muscles, the glottic larynx, and the supraglottic larynx may lead to dysphagia, an unwanted effect of head and neck radiotherapy. The reduction of radiotherapy-induced dysphagia might be achieved by adaptive radiotherapy. Although the number of studies concerning adaptive radiotherapy of head and neck cancer is continuously increasing, there are only a few studies concerning changes in dysphagia-related structures during radiotherapy.The goal of this review is to summarize the current knowledge about volumetric, dosimetric, and other changes of the pharyngeal constrictor muscles associated with head and neck radiotherapy. A literature search was performed in the MEDLINE database according to Preferred Reporting Items for Systematic Reviews and Meta-Analyses guidelines. The conclusions of 8 studies that passed the criteria indicate a significant increase in the volume and the thickness of the pharyngeal constrictor muscles during radiotherapy. Moreover, the changes in magnetic resonance imaging signal intensity of the pharyngeal constrictor muscles correlate with the absorbed dose (typically higher than 50 Gy) and also with the grade of dysphagia. This systematic review presents 2 variables, which are suitable for estimation of radiotherapy-related pharyngeal constrictor muscles changes-magnetic resonance imaging signal intensity and the thickness. In the case of the thickness, there is no consensus in the level of the measurement-C2 vertebra, C3 vertebra, and the middle of the craniocaudal axis are used. It seems that reference to a position associated with a vertebral body could be more reproducible and beneficial for future research. Although late pharyngeal toxicity remains a challenge in head and neck cancer treatment, better knowledge of radiotherapy-related changes in the pharyngeal constrictor muscles contributes to adaptive radiotherapy development and thus improves the treatment results.

Department of Oncology and Radiotherapy University Hospital Hradec Kralove Czech Republic

Department of Radiobiology Faculty of Military Health Sciences Hradec Kralove University of Defence Brno Czech Republic

000      

00000naa a2200000 a 4500

001      

bmc22004897

003      

CZ-PrNML

005      

20220127144842.0

007      

ta

008      

220113s2020 xxu f 000 0|eng||

009      

AR

024    7_

$a 10.1177/1533033820945805 $2 doi

035    __

$a (PubMed)32734851

040    __

$a ABA008 $b cze $d ABA008 $e AACR2

041    0_

$a eng

044    __

$a xxu

100    1_

$a Grepl, Jakub $u Department of Oncology and Radiotherapy, University Hospital, Hradec Kralove, Czech Republic $u Department of Radiobiology, Faculty of Military Health Sciences, Hradec Kralove, University of Defence, Brno, Czech Republic

245    14

$a The Changes in Pharyngeal Constrictor Muscles Related to Head and Neck Radiotherapy: A Systematic Review / $c J. Grepl, I. Sirak, M. Vosmik, A. Tichy

520    9_

$a It is well known that radiation damage of the pharyngeal constrictor muscles, the glottic larynx, and the supraglottic larynx may lead to dysphagia, an unwanted effect of head and neck radiotherapy. The reduction of radiotherapy-induced dysphagia might be achieved by adaptive radiotherapy. Although the number of studies concerning adaptive radiotherapy of head and neck cancer is continuously increasing, there are only a few studies concerning changes in dysphagia-related structures during radiotherapy.The goal of this review is to summarize the current knowledge about volumetric, dosimetric, and other changes of the pharyngeal constrictor muscles associated with head and neck radiotherapy. A literature search was performed in the MEDLINE database according to Preferred Reporting Items for Systematic Reviews and Meta-Analyses guidelines. The conclusions of 8 studies that passed the criteria indicate a significant increase in the volume and the thickness of the pharyngeal constrictor muscles during radiotherapy. Moreover, the changes in magnetic resonance imaging signal intensity of the pharyngeal constrictor muscles correlate with the absorbed dose (typically higher than 50 Gy) and also with the grade of dysphagia. This systematic review presents 2 variables, which are suitable for estimation of radiotherapy-related pharyngeal constrictor muscles changes-magnetic resonance imaging signal intensity and the thickness. In the case of the thickness, there is no consensus in the level of the measurement-C2 vertebra, C3 vertebra, and the middle of the craniocaudal axis are used. It seems that reference to a position associated with a vertebral body could be more reproducible and beneficial for future research. Although late pharyngeal toxicity remains a challenge in head and neck cancer treatment, better knowledge of radiotherapy-related changes in the pharyngeal constrictor muscles contributes to adaptive radiotherapy development and thus improves the treatment results.

650    _2

$a poruchy polykání $x etiologie $7 D003680

650    _2

$a nádory hlavy a krku $x komplikace $x diagnostické zobrazování $x radioterapie $7 D006258

650    _2

$a lidé $7 D006801

650    _2

$a magnetická rezonanční tomografie $7 D008279

650    12

$a kritické orgány $7 D058958

650    _2

$a faryngální svaly $x diagnostické zobrazování $x patologie $x účinky záření $7 D010609

650    _2

$a celková dávka radioterapie $7 D011879

650    _2

$a počítačová rentgenová tomografie $7 D014057

655    _2

$a časopisecké články $7 D016428

655    _2

$a metaanalýza $7 D017418

655    _2

$a práce podpořená grantem $7 D013485

700    1_

$a Sirak, Igor $u Department of Oncology and Radiotherapy, University Hospital, Hradec Kralove, Czech Republic

700    1_

$a Vosmik, Milan $u Department of Oncology and Radiotherapy, University Hospital, Hradec Kralove, Czech Republic

700    1_

$a Tichy, Ales $u Department of Radiobiology, Faculty of Military Health Sciences, Hradec Kralove, University of Defence, Brno, Czech Republic

773    0_

$w MED00185813 $t Technology in cancer research & treatment $x 1533-0338 $g Roč. 19, č. - (2020), s. 1533033820945805

856    41

$u https://pubmed.ncbi.nlm.nih.gov/32734851 $y Pubmed

910    __

$a ABA008 $b sig $c sign $y p $z 0

990    __

$a 20220113 $b ABA008

991    __

$a 20220127144839 $b ABA008

999    __

$a ok $b bmc $g 1752190 $s 1156046

BAS    __

$a 3

BAS    __

$a PreBMC

BMC    __

$a 2020 $b 19 $c - $d 1533033820945805 $e - $i 1533-0338 $m Technology in cancer research & treatment $n Technol Cancer Res Treat $x MED00185813

LZP    __

$a Pubmed-20220113